Paragon and NextDocs Introduce Clinical Optimization Solutions Targeting Life Sciences Firms
Paragon Solutions, a business consulting and information technology services firm, announced the launch of solutions to optimize clinical operations incorporating the NextDocs product suite. The clinical solutions combine the capabilities of the two partners to deploy low-risk, accelerated solutions for life sciences built on Microsoft Office SharePoint Server.
“With the growing adoption of SharePoint within Life Sciences organizations, companies are looking for solution accelerators that leverage enterprise platforms to optimize the end-to-end drug development process,” said Ravi Shankar, vice president of Paragon’s Life Sciences practice. “NextDocs extends SharePoint with capabilities that complement our Clinical Optimization solution strategy,” he said.
The solutions leverage a strategic partnership formed by the companies in September 2009. One of the solutions the companies are introducing as part of the Clinical Optimization Solution portfolio is an integrated investigator portal. The portal is designed to deliver a collaborative environment that enables clinical sponsors and investigators to: negotiate contracts; define and communicating protocols; support site monitoring; manage grants; work with partners; and improve oversight and planning.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
